Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Company Summary

InhaleRx Limited, a biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia. It is developing IRX-211 that has completed Phase 1 clinical trial for the treatment of Breakthrough Cancer Pain (BTcP); and IRX-616a that is in preclinical trial for panic disorder (PD). The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is headquartered in Melbourne, Australia.

Health Care
Medical Devices
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Articles